Stock listing

Stuttgart:609 ABIONYX Pharma SA Aktie

German listing (Stuttgart) of ABIONYX Pharma SA · home listing Euronext:ABNX

Follow ABIONYX Pharma SA into a list and get an email when it puts out news.

Home listing price · EURONEXT:ABNX

€1.55 EUR +0.06 (+4.2%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ABNX

Since Jul 6, 2026 -24.2% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
€1.48 – €1.57 EUROct 16, 2026
Volume
75,888 sharesOct 16, 2026
Market value
€67.72M EURAt the close on Oct 16, 2026 · price × 43.81M shares outstanding
ABIONYX Pharma SA logo
Ticker
Stuttgart:609
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

ABIONYX Pharma and OLON Enter Into Strategic Manufacturing Partnership to Prepare CER-001 Biologic for Regulatory Approval and Commercial Supply

Oct 7, 2026

ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

Oct 2, 2026

Information relative au nombre total de droits de vote et d’actions composant le capital social

Oct 2, 2026

ABIONYX Pharma Announces the Settlement of an Anticipated Amortization Payment in Accordance With the Terms of Its Bonds Financing Agreement

Oct 2, 2026

ABIONYX Pharma annonce le règlement d’un amortissement anticipé conformément aux termes de son contrat de Financement Obligataire

Oct 2, 2026

ABIONYX Pharma: Half Year Results 2026

Sep 23, 2026

ABIONYX Pharma Reaches Another Key Milestone in the Industrialization of CER-001 by Entering into a Strategic Partnership with TEXCELL (ABL Diagnostics) for the Viral Safety and Clearance of Biologics

Sep 10, 2026

ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the First Half of 2026

Aug 27, 2026

ABIONYX Pharma: Half-Year Review of the Liquidity Agreement Entered into with TP ICAP (Europe) SA

Jul 6, 2026

ABIONYX Pharma is Scaling up Its Operations After Securing the Resources Needed to Achieve Its Goals and Is Embarking on a New Cycle of Value Creation in the Treatment of Severe Inflammation and Sepsis

Jun 30, 2026

All ABIONYX Pharma SA news

Decks

ABIONYX Pharma SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
32 in the last 12 months · 37 in all · newest Oct 7, 2026 · oldest 2025
Decks
5 decks · latest March 2026

Where ABIONYX Pharma SA is listed

ListingExchangeCountryCurrency
Euronext:ABNX · Home listingEuronextFranceEUR
LS Exchange:A14QR9LS ExchangeGermanyEUR
gettex:609gettexGermanyEUR
LSE:0RAGLSEUnited KingdomEUR
Lang & Schwarz:A14QR9Lang & SchwarzGermanyEUR
Aquis:ABNXPAquisUnited KingdomEUR
Aquis:ABNXPAquisUnited KingdomEUR
Turquoise:ABNXPTurquoiseUnited KingdomEUR
Dusseldorf:609DusseldorfGermanyEUR
Frankfurt:609FrankfurtGermanyEUR
Hamburg:609HamburgGermanyEUR
Munich:609MunichGermanyEUR
Stuttgart:609 · This pageStuttgartGermanyEUR
Tradegate:609TradegateGermanyEUR

Log in to ask 6ix AI your own questions about ABIONYX Pharma SA.